Pyrogallol Red Molybdate dye binding method provides a simple, ready-to-use colorimetric method for total protein quantitation with greater linearity, using microliter samples of urine or cerebrospin
This control is intended as a means of monitoring serum cardiac analyte testing methods. A new feature is the addition of homocysteine, digoxin and CRP. It is compatible with most major chemistry ana
The Clearblue Easy Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the 2 best
...s a rapid in vitro qualitative test for the detect...Type 1 in human whole blood, serum or plasma. The ...edical facilities, clinical laboratories, emergenc...reening assay capable of providing test results in...
Medicine Products:(Date:12/3/2008)...re/ -- Health Analytic Services,today announced i...ition, and,fitness information on iPhone and iPod... The application provides mobile access to TheCarr...e a user,s well-being. , "Powerful wireless...interface has enabled us to create the perfect com...
(Date:12/3/2008)...arch team led by the La Jolla Institute for Allerg...minated the important role of natural killer (NK) ...ce little understood white blood cells are central...the intensity and duration of arthritis associated... NK T cells are critical to preventing the chronic...
(Date:12/3/2008)...ular cause behind the ravages of old age and in do...ighting cancer in younger persons can actually pro...nce, the process by which biological cells stop di...A, was shown to trigger the secretion of proteins ...issue. Inflammation is linked to almost every majo...
(Date:12/3/2008)...e/ -- Ten students pursuing health care careers in...2,000 scholarships from the National Hispanic Heal...Health Professional Student Scholarship Gala at 7 ...tel. , , The scholarship program was suppo...000 for $5,000 awards to the top three students. O...
Breaking Medicine News(10 mins):Health News:TheCarrot.com Launches Mobile Health and Wellness Tracking Application on Apple App Store 2Health News:Researchers identify cell group key to Lyme disease arthritis 2Health News:Researchers identify cell group key to Lyme disease arthritis 3Health News:Cellular senescence a double-edged sword 2Health News:Cellular senescence a double-edged sword 3Health News:Cellular senescence a double-edged sword 4Health News:Cellular senescence a double-edged sword 5Health News:NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals 2(Date:12/3/2008)...wswire-FirstCall/ -- Isis Pharmaceuticals,Inc. (...armaceuticals, Inc.,provided positive survival re...,OGX-011 in combination with docetaxel and prednis... prednisone alone ("the control arm") for first-li...state cancer. The current 10.6,month median over...
(Date:12/2/2008)...wswire-FirstCall/ -- Biopure Corporation,(Nasdaq:...cal Research Center,(NMRC) has submitted to the F...tigational new drug (IND) application to conduct a...ic Hemopure(R) [hemoglobin glutamer - 250 (bovine)...rauma patients. The study is,entitled "Operation ...
(Date:12/1/2008)...Newswire/ -- New research has found that the avail...phy (CT) scanner in an emergency room can signific...ceive a potentially life-saving treatment. Results...nter (NSMC)-Salem Hospital in Salem, Mass., will b...iological Society of North America (RSNA). , ,...
(Date:12/1/2008)...re/ -- Roche announced today that a,comparative s...d pain and,discomfort associated with blood gluco...ing systems and lancing devices were deemed least ... the ACCU-CHEK Aviva and ACCU-CHEK Compact,Plus b...Multiclix, ACCU-CHEK,Softclix and ACCU-CHEK Softc...
Breaking Medicine Technology:Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 1Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 2Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 1Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 2Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 3Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 4Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 5Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 6Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 7Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 8Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 9Providence Service Corporation Announces 187 25 Revenue Increase in First Quarter of 2008 18723 10Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 1Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 2Amnis and Gene Company Ltd Announce Agreement to Market ImageStream Technology in China 5201 1Amnis and Gene Company Ltd Announce Agreement to Market ImageStream Technology in China 5201 2...is with Synagis Decreases Incidence of Recurrent W...RSBURG, Md., June 29, 2007,/PRNewswire-FirstCall/ ... a new study, published in the July issue of Journ...gis(R) (palivizumab),may reduce recurrent wheezing...ly, the study showed that premature infants withou...
...lash;, Norway, June 29, 2007-Preliminary results f... Sloan-Kettering,Cancer Center show a very good sa...ponses on cancer development have been observed,am...BG in,combination with the monoclonal antibody aga...escribed in the company,s report for,the 1st quart...
Other Medicine Technology:New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 2Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 3